Back to Search
Start Over
European patent office allows Advaxis/U Penn modified LLO patent
- Source :
- Chemical Business Newsbase. August 24, 2010
- Publication Year :
- 2010
-
Abstract
- Advaxis Inc, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has been notified by the European Patent Office that patent application WO2001/072329, for the use of Prokaryotic PEST-Like Peptides for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Chemical Business Newsbase
- Publication Type :
- News
- Accession number :
- edsgcl.236156635